Heim0882 • HKG
add
Tianjin Development Holdings Ltd
Við síðustu lokun
1,92 $
Dagbil
1,92 $ - 1,94 $
Árabil
1,38 $ - 2,17 $
Markaðsvirði
2,09 ma. HKD
Meðalmagn
710,94 þ.
V/H-hlutf.
3,77
A/V-hlutfall
7,21%
Aðalkauphöll
HKG
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(HKD) | jún. 2024info | Breyting á/á |
---|---|---|
Tekjur | 910,13 m. | -0,56% |
Rekstrarkostnaður | 244,94 m. | -6,16% |
Nettótekjur | 144,04 m. | -22,46% |
Hagnaðarhlutfall | 15,83 | -22,02% |
Hagnaður á hvern hlut | — | — |
EBITDA | 102,49 m. | 12,31% |
Virkt skatthlutfall | 7,79% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(HKD) | jún. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 6,53 ma. | 21,31% |
Heildareignir | 22,13 ma. | 2,78% |
Heildarskuldir | 4,86 ma. | -1,54% |
Eigið fé alls | 17,27 ma. | — |
Útistandandi hlutabréf | 1,07 ma. | — |
Eiginfjárgengi | 0,16 | — |
Arðsemi eigna | 0,56% | — |
Ávöxtun eigin fjár | 0,64% | — |
Peningaflæði
Breyting á handbæru fé
(HKD) | jún. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 144,04 m. | -22,46% |
Handbært fé frá rekstri | -173,05 m. | 63,96% |
Reiðufé frá fjárfestingum | -148,02 m. | 10,91% |
Reiðufé frá fjármögnun | 22,44 m. | -69,54% |
Breyting á handbæru fé | -307,01 m. | 48,60% |
Frjálst peningaflæði | 67,46 m. | 5,22% |
Um
Tianjin Development Holdings Limited or Tianjin Development is a conglomerate engaged in container terminal operations, toll roads, water supply, electric utilities, pharmaceuticals and property development in Tianjin, China. In 2005, Tianjin Development split Tianjin Port Development to be listed on the Hong Kong Stock Exchange.
On 22 July 2015, a subsidiary of Tianjin Development agreed to acquire from Tianjin Pharmaceutical Group Co., Ltd. 67% shares of the issued share capital of Thrive Leap Limited at a consideration of RMB 2.3 billion. Thrive Leap Limited indirectly holds approximately 51.36% of the total issued A shares in Tianjin Lisheng Pharmaceutical Co., Ltd., 65% equity interest in Tianjin Yiyao Printing Co., Ltd., and 100% equity interest Tianjin Institute of Pharmaceutical Research Co., Ltd. Wikipedia
Stofnsett
9. maí 1997
Vefsvæði
Starfsfólk
2.684